J.-D. Chiche (Paris, France), J. Pugin (Geneva, Switzerland)
Late-breaking abstract: Effects of oleanolic acid on pulmonary morphofunctional and biochemical variables in experimental sepsis
R. Santos, P. Silva, G. Oliveira, F. Cruz, M. Ramos, E. Assis, H. Faria-Neto, C. Gattass, P. Rocco (Rio de Janeiro, Brazil)
|  |
Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP)
M. Ferrer, P. Ramirez, V. Marti, S. Reyes, R. Martinez, R. Menendez, S. Ewig, A. Torres (Barcelona, Valencia, Spain; Bochum, Germany)
|   |
Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance
H. Remmelts, S. Meijvis, G. Rijkers, H. van Velzen-Blad, P. Voorn, J. Grutters, W. J. Bos, D. Biesma (Nieuwegein, Utrecht, Netherlands)
| |
Impact of bronchoalveolar lavage (BAL) multiplex PCR with DNA macrocip based diagnosis on outcomes of severe pneumonia in ICU
M. Sircar, R. Kaur, R. Gupta, P. Ranjan, R. Tangri, A. Gupta, R. Caroli, N. Chavhan, A. Joshi Bhatt, S. Naaz, V. Taneja, S. Kumar, M. Singh (Noida, India)
| |
Hyaluronan infusion improves survival in endotoxemic rats
W. I. Choi, H. Charles (Daegu, Republic Of Korea; Boston, United States Of America)
| |
Multi organ failure in severe sepsis patients followed at intensive care unit: Risk factors
Z. Karakurt, O. Yazicioglu Mocin, E. Oz, N. Adiguzel, G. Gungor, O. Devran, M. Kalamanoglu Balci, A. Yilmaz (Istanbul, Turkey)
| |
Prediction of clinical severity and outcome of ventilator-associated pneumonia in a tertiary hospital using the VAP PIRO scoring system
R. Panaligan, C. Chavez, M. Panaligan (Manila, Philippines)
| |
De-escalation therapy in ventilator acquired pneumonia (VAP)
A. Khoury, H. Al-Nasser, F. Al-Hamad, H. Hannan (Aleppo, Syrian Arab Republic)
| |